Back to Search
BACH ARDALAN MD
MD
Hematology & Oncology Physician
NPI: 1356385140IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME59464(FL)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME59464(FL)
Education
OTHER
Class of 1970
Research & Publications (13)
Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.
PMID 17704532·Jpn J Clin Oncol·2007
3-trial
A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancer.
PMID 17667602·Anticancer Drugs·2007
3-trial
A phase II trial of FUdR in patients with advanced pancreatic cancer.
PMID 15449185·J Cancer Res Clin Oncol·2004
3-trial
Differential expression of Glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types.
PMID 18343752·J Chemother·2008
8-other
Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: a clinical experience.
PMID 17497326·Acta Oncol·2007
3-trial
Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer.
PMID 16771940·Am J Gastroenterol·2006
8-other
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.
PMID 15292717·Invest New Drugs·2004
3-trial
Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines.
PMID 15205948·J Cancer Res Clin Oncol·2004
8-other
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
PMID 15122082·Invest New Drugs·2004
3-trial
Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial.
PMID 12618896·J Cancer Res Clin Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1475 NW 12TH AVE
MIAMI, FL 33136 - Phone
- (305) 243-1000
Quick Facts
- NPI
- 1356385140
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 56
- Publications
- 13
Are you this provider?
Claim Your Profile